Your browser doesn't support javascript.
loading
Risk Factors for Hepatic Encephalopathy in Hepatocellular Carcinoma After Sorafenib or Lenvatinib Treatment: A Real-World Study.
Chen, Bowen; Zhang, Linzhi; Cheng, Jiamin; Wu, Tong; Lei, Jin; Yang, Xu; Zhang, Rongling; Safadi, Rifaat; Li, Yinyin; Si, Tongguo; Lu, Yinying.
Affiliation
  • Chen B; Peking University 302 Clinical Medical School, Beijing, People's Republic of China.
  • Zhang L; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Cheng J; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Wu T; Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Lei J; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Yang X; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Zhang R; Senior Department of Hepatology, the 5th Medical Center of the PLA General Hospital, Beijing, People's Republic of China.
  • Safadi R; Guizhou Medical University, Guiyang, People's Republic of China.
  • Li Y; Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Si T; Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
  • Lu Y; Liver Unit, Hadassah-Hebrew University Hospital, Jerusalem, Israel.
Drug Des Devel Ther ; 16: 4429-4437, 2022.
Article de En | MEDLINE | ID: mdl-36597443
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Quinoléines / Encéphalopathie hépatique / Carcinome hépatocellulaire / Tumeurs du foie / Antinéoplasiques Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Drug Des Devel Ther Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2022 Type de document: Article Pays de publication: Nouvelle-Zélande
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Quinoléines / Encéphalopathie hépatique / Carcinome hépatocellulaire / Tumeurs du foie / Antinéoplasiques Type d'étude: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: Drug Des Devel Ther Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2022 Type de document: Article Pays de publication: Nouvelle-Zélande